Login
Super Investors / 22NW, LP
2

22NW, LP

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$105M
Positions
14
Quarter ended
June 30, 2026
Filed
August 14, 2026

Reported portfolio value by quarter (39 quarters reported)

$372M $75.8M
Q4 16 Q4 18 Q4 20 Q4 22 Q4 24 Q2 26

$167M in Q4 2016 → $105M now. Hover for any quarter.

Holdings

As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
Insperity Inc 19.5% Unchanged 493,000 $20.4M
Nektar Therapeutics 18.7% Unchanged 281,115 $19.6M
Stoneridge Inc 17.3% Unchanged 2,466,975 $18.1M
FF Fox Factory Hldg Corp 11.0% Unchanged 678,165 $11.5M
CM Core Molding Technologies In 6.2% Added 23% 273,521 $6.46M
Regenxbio Inc 5.6% Unchanged 492,759 $5.9M
Culp Inc 5.5% Unchanged 1,859,061 $5.76M
Rezolute Inc 4.1% Unchanged 820,653 $4.27M
Unifi Inc 3.9% Unchanged 852,455 $4.05M
Mineralys Therapeutics Inc 2.9% Trimmed 74% 113,840 $3.07M
Team Inc 2.8% Unchanged 170,187 $2.94M
Eledon Pharmaceuticals Inc 2.4% Unchanged 636,364 $2.51M
Turtle Beach Corp 0.2% New 14,430 $180K
LB Lifecore Biomedical Inc 0.0% Unchanged 1,254 $6.22K

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q2 2026

quarter ended June 30, 2026 · filed August 14, 2026

Company Action Shares changed Value of change % of portfolio
Foster L B Co Exited −1,067,186 −$29.8M
Mineralys Therapeutics Inc Trimmed −330,485 −$8.92M 2.9%
FB Farmer Bros Co Exited −1,955,526 −$2.48M
Phenixfin Corp Exited −43,115 −$1.68M
CM Core Molding Technologies In Added +50,783 +$1.2M 6.2%
Turtle Beach Corp New +14,430 +$180K 0.2%

Q1 2026

quarter ended March 31, 2026 · filed May 15, 2026

Company Action Shares changed Value of change % of portfolio
Anebulo Pharmaceuticals Inc Exited −15,467,300 −$84.8M
FF Fox Factory Hldg Corp New +678,165 +$11.2M 7.7%
Insperity Inc Added +396,700 +$10.7M 9.1%
ME Mayville Engr Co Inc Exited −414,280 −$7.76M
MH Meiragtx Hldgs PLC Exited −586,519 −$4.66M
Regenxbio Inc Trimmed −430,920 −$3.61M 2.8%
Nektar Therapeutics Trimmed −50,000 −$3.6M 13.9%
Foster L B Co Trimmed −123,860 −$3.46M 20.4%
Phenixfin Corp Trimmed −74,770 −$2.92M 1.2%
Mineralys Therapeutics Inc Added +86,000 +$2.33M 8.2%

Showing the 10 largest of 13 changes.

Q4 2025

quarter ended December 31, 2025 · filed February 13, 2026

Company Action Shares changed Value of change % of portfolio
Dhi Group Inc Exited −2,036,988 −$5.66M
AS Aebi Schmidt Hldg Ag Exited −347,840 −$4.34M
Insperity Inc New +96,300 +$3.73M 1.6%
Foster L B Co Trimmed −122,075 −$3.29M 13.5%
Stoneridge Inc Added +87,164 +$505K 5.3%
Unifi Inc Trimmed −125,184 −$438K 1.3%
ME Mayville Engr Co Inc Added +14,390 +$269K 3.3%

Q3 2025

quarter ended September 30, 2025 · filed November 14, 2025

Company Action Shares changed Value of change % of portfolio
LB Lifecore Biomedical Inc Trimmed −262,926 −$4.22B 9.5%
Nektar Therapeutics Added +185,000 +$10.5M 8.9%
Rezolute Inc New +820,653 +$7.71M 3.6%
Mineralys Therapeutics Inc Trimmed −201,717 −$7.65M 6.4%
AS Aebi Schmidt Hldg Ag New +347,840 +$4.34M 2.0%
Dhi Group Inc Trimmed −1,262,949 −$3.51M 2.7%
ME Mayville Engr Co Inc Added +244,440 +$3.36M 2.6%
Arvinas Inc Exited −413,533 −$3.04M
Compass Pathways PLC Exited −882,844 −$2.47M
Stoneridge Inc Added +162,092 +$1.24M 7.6%

Showing the 10 largest of 13 changes.

Q2 2025

quarter ended June 30, 2025 · filed August 14, 2025

Company Action Shares changed Value of change % of portfolio
LB Lifecore Biomedical Inc Trimmed −1,490,981 −$128M 14.2%
Sterling Infrastructure Inc Exited −99,783 −$11.3M
BB Barrett Business Svcs Inc Exited −132,452 −$5.45M
MH Meiragtx Hldgs PLC New +586,519 +$3.82M 2.4%
Nektar Therapeutics New +146,115 +$3.78M 2.4%
CM Core Molding Technologies In New +191,222 +$3.17M 2.0%
Arvinas Inc New +413,533 +$3.04M 1.9%
ME Mayville Engr Co Inc New +155,450 +$2.48M 1.6%
Team Inc Added +136,255 +$2.48M 2.0%
Stoneridge Inc Added +315,855 +$2.22M 8.6%

Showing the 10 largest of 19 changes.

Q1 2025

quarter ended March 31, 2025 · filed May 14, 2025

Company Action Shares changed Value of change % of portfolio
Mineralys Therapeutics Inc New +461,344 +$7.33M 4.9%
Stoneridge Inc Added +1,284,866 +$5.9M 5.0%
BB Barrett Business Svcs Inc Trimmed −132,452 −$5.45M 3.7%
Regenxbio Inc New +668,679 +$4.78M 3.2%
Manitowoc Co Inc Exited −356,115 −$3.25M
LH Lantheus Hldgs Inc Exited −34,562 −$3.09M
Unifi Inc Added +497,758 +$2.39M 2.4%
Eledon Pharmaceuticals Inc New +636,364 +$2.16M 1.4%
Compass Pathways PLC New +646,559 +$1.85M 1.2%
Keros Therapeutics Inc New +179,000 +$1.82M 1.2%

Showing the 10 largest of 14 changes.

Q4 2024

quarter ended December 31, 2024 · filed February 14, 2025

Company Action Shares changed Value of change % of portfolio
Anebulo Pharmaceuticals Inc Added +10,101,010 +$17M 16.4%
Stoneridge Inc New +342,787 +$2.15M 1.4%
Nektar Therapeutics New +2,191,750 +$2.04M 1.3%
Unifi Inc New +233,777 +$1.46M 0.9%
Psychemedics Corp Exited −276,034 −$638K
PC Psychemedics Corporation Cmn New +276,034 +$618K 0.4%
Culp Inc Added +30,325 +$178K 6.0%

Q3 2024

quarter ended September 30, 2024 · filed November 14, 2024

Company Action Shares changed Value of change % of portfolio
Culp Inc Added +357,601 +$2.34M 8.8%
Dhi Group Inc Added +535,153 +$985K 4.0%
Psychemedics Corp Added +1,616 +$3.73K 0.5%

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support